Hirshfeld defends IPR review authority under Arthrex

03-02-2022

Alex Baldwin

Hirshfeld defends IPR review authority under Arthrex

Mark Van Scyoc / Shutterstock.com

The acting director of the US Patent and Trademark Office (USPTO) Andrew Hirshfeld has defended his right to review final Patent Trial and Appeal Board (PTAB) decisions under  Arthrex.


Andrew Hirshfeld, USPTO, IPR, PTAB, VirnetX, Apple, patents

WIPR